Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple Sclerosis: Symptomatic Treatment.

C T Bever1

  • 1Department of Neurology, University of Maryland, The Maryland Center for Multiple Sclerosis and Neurology and Research Services, VAMHCS, 22 South Greene St., Baltimore, MD 21201, USA.

Current Treatment Options in Neurology
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.

Neurology·2011
Same author

Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.

Neurology·2010
Same author

Invited article: Neurology and quality improvement: an introduction.

Neurology·2008
Same author

Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology [RETIRED].

Neurology·2007
Same author

Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription.

Neurochemical research·2001
Same author

The cost of delaying treatment in multiple sclerosis: what is lost is not regained.

Neurology·2001
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Managing symptoms in multiple sclerosis (MS) remains crucial, even with new therapies. Recognizing and treating common non-neurologic symptoms like pain and fatigue is key to improving patient disability.

Area of Science:

  • Neurology
  • Symptom Management

Background:

  • Disease-modifying therapies for multiple sclerosis (MS) do not cure the condition or reverse existing deficits.
  • Many patients with MS experience persistent neurologic and non-neurologic symptoms that significantly impact disability.
  • Commonly observed non-neurologic symptoms include pain, fatigue, and mood disturbances.

Purpose of the Study:

  • To emphasize the ongoing importance of symptom management in multiple sclerosis (MS) despite advancements in disease-modifying therapies.
  • To highlight the need for recognizing and addressing both neurologic and non-neurologic symptoms in MS patients.
  • To outline current and emerging strategies for managing persistent symptoms in multiple sclerosis.

Main Methods:

  • Ongoing patient-physician dialogue to identify and discuss symptoms.

Related Experiment Videos

  • Recognition of treatable symptoms and application of appropriate management strategies.
  • Exploration of experimental agents, such as potassium channel blockers, for potential functional improvement.

    • Main Results:

    • Persistent symptoms are common in multiple sclerosis (MS) patients, necessitating continued management.
    • Non-neurologic symptoms like pain, fatigue, and mood disturbances are prevalent and contribute to disability.
    • Experimental treatments, including potassium channel blockers, show promise for improving function in demyelinated pathways.

    Conclusions:

    • Symptom management is a critical component of comprehensive care for multiple sclerosis (MS) patients.
    • A multi-faceted approach, including medication, lifestyle adjustments, rehabilitation, and potentially surgery, is required for effective symptom control.
    • Further research into agents like potassium channel blockers may offer new avenues for treating a range of MS symptoms.